A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern.
Bárbara M SchultzFelipe Melo-GonzálezLuisa F DuarteNicolás M S GálvezGaspar A PachecoJorge A SotoRoslye V Berríos-RojasLiliana A GonzálezDaniela Moreno-TapiaDaniela Rivera-PérezMariana RíosYaneisi VázquezGuillermo Hoppe-ElsholzOmar P VallejosCarolina IturriagaMarcela UrzuaMaría S NavarreteÁlvaro RojasRodrigo FasceJorge FernándezJudith MoraEugenio RamírezAracelly Gaete-ArgelMónica AcevedoFernando Valiente-EcheverríaRicardo Soto-RifoDaniela WeiskopfAlba GrifoniAlessandro SetteGang ZengWeining Mengnull nullJosé Vicente González-AramundizGonzález PaKatia AbarcaAlexis M KalergisSusan M BuenoPublished in: medRxiv : the preprint server for health sciences (2022)
is active against VOC, suggesting an effective protection.